Skip Navigation
United States Flag

An official website of the United States government. Here's how you know >

Change Font Size

Increase in Prices for Brand-Name Drugs Under Part D

Prices for the most commonly used brand-name drugs have risen substantially since 2002.  For example, prices for the most commonly used brand-name drugs increased nearly 13 percent in 2013; this increase was 8 times greater than the general inflation rate for the same year.  We will evaluate the extent to which pharmacy reimbursement for brand-name drugs under Medicare Part D changed between 2011 and 2015 and compare the rate of change in pharmacy reimbursement for brand-name drugs under Medicare Part D to the rate of inflation for the same period.

Announced or Revised Agency Title Component Report Number(s) Expected Issue Date (FY)
Nov-16 Centers for Medicare & Medicaid Services Increase in Prices for Brand-Name Drugs Under Part D Office of Evaluation and Inspections OEI-03-15-00080 2018

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201